Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71205-246

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71205-246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-246-90 (Atorvastatin 10 mg 30 Bottle Label)

71205-246-90 (Atorvastatin 10 mg 30 Bottle Label)
Label for Atorvastatin Calcium 10 mg film coated tablets, #30 count, produced by Intas Pharmaceuticals Limited and packaged by Proficient Rx LP. The label notes the tablets are white to off-white, oval, biconvex, and debossed with "FF1" on one side. It includes storage instructions and multiple barcode and QR code elements.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 1)

Figure (Atorvastatin Calcium Figure 1)
A line graph showing cumulative incidence (%) over years (0 to 3.5) comparing Atorvastatin (solid line) and Placebo (dashed line). The graph illustrates a lower cumulative incidence for Atorvastatin compared to Placebo, with a hazard ratio (HR) of 0.64 (0.50-0.83) and a p-value of 0.0005.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 2)

Figure (Atorvastatin Calcium Figure 2)
A Kaplan-Meier survival curve showing cumulative hazard (%) over time to first primary endpoint through four years of follow-up comparing Atorvastatin to placebo. The graph displays lower cumulative hazard with Atorvastatin versus placebo, with hazard ratio (HR) 0.63 (0.48-0.83) and p=0.001.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 3)

Figure (Atorvastatin Calcium Figure 3)
A line graph comparing the percentage of subjects experiencing major cardiovascular events over time between Atorvastatin 10 mg and 80 mg doses. The x-axis shows time in years up to 5, and the y-axis shows the percentage of subjects experiencing the event, with the 10 mg group having a higher event rate than the 80 mg group. The graph includes a hazard ratio (HR=0.78) with confidence interval and p-value.*
FDA Label Image

Chemical Structure (Atorvastatin Calcium Structure)

Chemical Structure (Atorvastatin Calcium Structure)
Chemical structure diagram of atorvastatin calcium, including the calcium ion and water of hydration components as part of the salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.